GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...

The future of the Saudi Arabia Diabetes Nutrition market in 2032 is promising, with a growing emphasis on personalized nutrition, functional foods, and holistic diabetes management. Staying ahead of ...

The FreeStyle Libre by Abbott can provide prick-free on-demand sugar readings that offer detailed insights with just a scan ...

Sanctuary Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the second ...

In the UK, more than 5.6 million individuals manage their diabetes with the aid of insulin pumps or continuous glucose ...

Millions across the UK have been alerted as concerns arise over insufficient reporting issues related to a vital device. An ...

Trinity Biotech’s Chief Technology Officer, Dr Gary Keating, added, “Our next phase of refinements, guided by this study’s positive results, will be tested in a second European pre-pivotal trial, ...

Biosensors that measure glucose are now available without a prescription. Wearing one nearly burst my wellness bubble.

The medical industry is on the fence of explosive growth, fueled by technological advancements. In this evolving landscape, ...

Many people with Type 1 diabetes will get "artificial pancreas" technology for free this year thanks to deals secured by ...